United Bank (Virginia)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.76M Sell
61,418
-701
-1% -$92.4K 0.91% 34
2026
Q1
$8.66M Sell
62,119
-2,726
-4% -$382K 1.11% 29
2025
Q4
$7.96M Sell
64,845
-13,493
-17% -$1.64M 1.05% 30
2025
Q3
$8.7M Sell
78,338
-4,847
-6% -$551K 1.04% 34
2025
Q2
$9.22M Buy
83,185
+6,866
+9% +$731K 1.1% 33
2025
Q1
$8.55M Buy
+76,319
New +$7.87M 1.09% 33
2018
Q2
Sell
-4,479
Closed -$338K 127
2018
Q1
$338K Hold
4,479
0.08% 103
2017
Q4
$321K Buy
4,479
+1,263
+39% +$95.9K 0.08% 112
2017
Q3
$261K Hold
3,216
0.25% 43
2017
Q2
$228K Hold
3,216
0.22% 44
2017
Q1
$218K Hold
3,216
0.22% 44
2016
Q4
$230K Sell
3,216
-1,026
-24% -$76.3K 0.28% 44
2016
Q3
$336K Sell
4,242
-1,336
-24% -$109K 0.36% 46
2016
Q2
$465K Hold
5,578
0.46% 43
2016
Q1
$513K Sell
5,578
-16
-0.3% -$1.44K 0.51% 42
2015
Q4
$566K Hold
5,594
0.68% 33
2015
Q3
$549K Buy
+5,594
New +$621K 0.75% 33

Other funds holding GILD

United Bank (Virginia)'s GILD Position: Q2 2026 in Review

United Bank (Virginia) reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $92.4K and leaving 61,418 shares worth $7.76M. The position accounts for 0.91% of the portfolio, ranked #34.

United Bank (Virginia) first reported a position in GILD in Q3 2015 and has held it in 17 quarters since. The position peaked at $9.22M in Q2 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • United Bank (Virginia) held 61,418 shares of Gilead Sciences worth $7.76M as of Q2 2026.
  • United Bank (Virginia) sold 701 Gilead Sciences shares in Q2 2026, an estimated $92.4K.
  • Gilead Sciences made up 0.91% of United Bank (Virginia)'s portfolio in Q2 2026, its #34 holding.
  • United Bank (Virginia) first reported a position in Gilead Sciences in Q3 2015 and has held it in 17 quarters since.
  • United Bank (Virginia)'s Gilead Sciences position peaked at $9.22M in Q2 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on United Bank (Virginia)'s 13F filing for Q2 2026, filed 30 Jul 2026.